Applied Dna Sciences Stock Today
| APDN Stock | USD 0.16 0.01 5.88% |
Performance0 of 100
| Odds Of DistressOver 84
|
Applied DNA is selling at 0.16 as of the 26th of November 2024; that is 5.88 percent decrease since the beginning of the trading day. The stock's open price was 0.17. Applied DNA has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Applied DNA Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Business Domain Technology Hardware & Equipment | IPO Date 15th of July 2003 | Category Healthcare | Classification Information Technology |
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company has 50.48 M outstanding shares of which 611.1 K shares are presently shorted by private and institutional investors with about 0.12 trading days to cover. More on Applied DNA Sciences
Moving against Applied Stock
| 0.87 | T | ATT Inc Sell-off Trend | PairCorr |
| 0.82 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.82 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.82 | HD | Home Depot | PairCorr |
| 0.78 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.77 | WMT | Walmart Aggressive Push | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Fiscal Year End 5th of December 2024
Applied Stock Highlights
| President Chairman | ScD Hayward | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Electronic Equipment, Instruments & Components, Technology Hardware & Equipment, Information Technology, NASDAQ Composite, NASDAQ Composite Total, Information Technology, Electronic Equipment, Instruments & Components, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsApplied DNA can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Applied DNA's financial leverage. It provides some insight into what part of Applied DNA's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Applied DNA Sciences (APDN) is traded on NASDAQ Exchange in USA. It is located in 50 Health Sciences Drive, Stony Brook, NY, United States, 11790 and employs 52 people. Applied DNA is listed under Electronic Equipment, Instruments & Components category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.07 M. Applied DNA Sciences conducts business under Electronic Equipment, Instruments & Components sector and is part of Information Technology industry. The entity has 50.48 M outstanding shares of which 611.1 K shares are presently shorted by private and institutional investors with about 0.12 trading days to cover.
Applied DNA Sciences currently holds about 4.68 M in cash with (6.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Applied DNA Probability Of Bankruptcy
Ownership AllocationApplied DNA holds a total of 50.48 Million outstanding shares. Almost 98.89 percent of Applied DNA outstanding shares are held by general public with 0.62 (percent) owned by insiders and only 0.49 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Applied Ownership Details
Applied Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Belvedere Trading Llc | 2024-09-30 | 633 | |
| Wells Fargo & Co | 2024-06-30 | 141 | |
| Activest Wealth Management | 2024-06-30 | 101 | |
| Royal Bank Of Canada | 2024-06-30 | 85.0 | |
| Ubs Group Ag | 2024-06-30 | 76.0 | |
| Bank Of America Corp | 2024-06-30 | 30.0 | |
| Advisor Group Holdings, Inc. | 2024-06-30 | 2.0 | |
| Dakota Community Bank & Trust Na | 2024-09-30 | 2.0 | |
| Ground Swell Capital, Llc | 2024-09-30 | 0.0 | |
| Amh Equity Ltd | 2024-09-30 | 514.7 K | |
| Geode Capital Management, Llc | 2024-09-30 | 106.7 K |
Applied DNA Historical Income Statement
Applied Stock Against Markets
Applied DNA Corporate Management
| CPA CPA | Chief Officer | Profile | |
| Warren Pearlson | Sales Consultant | Profile | |
| Tony Benson | Managing EMEA | Profile | |
| Janice Meraglia | G VP | Profile | |
| JD Esq | Chief Development | Profile | |
| Joseph Magno | Sales Consultant | Profile | |
| MeiLin Wan | VP Sales | Profile |
Already Invested in Applied DNA Sciences?
The danger of trading Applied DNA Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Applied DNA is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Applied DNA. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Applied DNA Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Applied DNA Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Applied DNA's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Applied Dna Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Applied Dna Sciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Applied DNA Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Electronic Equipment, Instruments & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Applied DNA. If investors know Applied will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Applied DNA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.73) | Revenue Per Share 2.202 | Quarterly Revenue Growth (0.73) | Return On Assets (0.57) | Return On Equity (0.76) |
The market value of Applied DNA Sciences is measured differently than its book value, which is the value of Applied that is recorded on the company's balance sheet. Investors also form their own opinion of Applied DNA's value that differs from its market value or its book value, called intrinsic value, which is Applied DNA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Applied DNA's market value can be influenced by many factors that don't directly affect Applied DNA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Applied DNA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Applied DNA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Applied DNA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.